The agreement covering the Tour de France, is part of the cooperation agreement between the UCI on the one hand, represented by the CADF, and the AFLD on the other, which aims to ensure efficient anti-doping controls at all the major cycling competitions in France.

Regarding anti-doping controls for the Tour de France 2017, a comprehensive approach will prevail to maximise the efficiency of the control system, including targeted controls at the start of the competition – in particular through data exchange regarding the localisation of the riders – as well as the sharing of information concerning the Athlete Biological Passport (ABP), the individual electronic file for each rider that contains the results of all the anti-doping tests carried out as part of this programme over a certain period.

Several control measures already in place in recent editions will be renewed, such as: